Market Review and Trends
Smart Thought Of The Week: MVP
By The Smart Investor  •  September 12, 2020
The pausing of COVID-19 vaccine trials at AstraZeneca is a timely reminder that nothing in the sphere of scientific research is ever guaranteed. So, anyone who claims we could have a vaccine before November is either delusional or doesn’t understand science or both. That is not to say that the clinical trials won’t be resumed. But a vaccine that could be rolled out to billions of people around the world needs to be 100% safe. And a few short months is not long enough to determine if the vaccine will have any long-term adverse effects…. …. It might work at preventing viral infections in thousands of test subjects. But that should only be just one of many considerations. A bigger question would be how might a vaccine that is, say, derived from an adenovirus virus found in chimpanzees affects us and future generations? That is not something that can be answered in a matter of months....
Read the full article
By The Smart Investor
The Smart Investor is co-founded by David Kuo, Joanna Sng, and Chin Hui Leong. The company was formed in late 2019 from the ashes of the Motley Fool Singapore. The Smart Investor believes that everybody can learn how to invest, smartly. We aim to educate people on how to invest smartly by providing investing education, stock commentary and market coverage for Singapore and around the world.
LEAVE A COMMENT
LEAVE A COMMENT

Your email address will not be published.

*

Your Email Address will not be published
*

Read More Articles
More from thefinance